Ottawa: Canada’s health department on Wednesday continues to back AstraZeneca Plc’s COVID-19 vaccine even as it updated its label to provide information on rare blood clots associated with a low platelet count following an immunization shot. Health Canada said it has not received any reports of these blood clots to date. Canada, which is using AstraZeneca doses manufactured at the Serum Institute of India, has received 500,000 Covishield doses and expects to get 1.5 million more by May. The warning label informs people to seek immediate medical attention if they develop shortness of breath, chest pain, leg swelling, or persistent abdominal pain following AstraZeneca shots. Medical attention
Hence then, the article about canada adds blood clot warning to astrazeneca covid 19 vaccine was published today ( ) and is available onGulf News ( United Arab Emirates ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Canada adds blood clot warning to AstraZeneca COVID-19 vaccine )